Proterra Inc. announced the appointment of Jeffrey Embt as Chief Accounting Officer (CAO), effective June 8, 2023. Mr. Embt brings nearly 20 years of corporate accounting and financial management experience to Proterra. Prior to joining Proterra, Mr. Embt served as Head of Finance of BWXT Medical, a manufacturer of radiopharmaceuticals, radiotherapies, and medical isotopes.

He previously held roles in technical accounting with companies including BWX Technologies and within the audit practice of Deloitte. A Certified Public Accountant, Mr. Embt holds a Bachelor of Science in Accounting and Finance from Coastal Carolina University.